A 52-year-old man with COPD on inhaled beclomethasone dipropionate 200 µg twice daily for 2 years presents with progressive bone pain and a history of multiple fragility fractures. To evaluate the extent of bone loss attributable to chronic ICS use, which investigation is most appropriate?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.